Mylan Granted Final Approval for Zaleplon Capsules
Posted on: Tuesday, 10 June 2008, 09:01 CDT
Mylan has announced that its subsidiary, Genpharm ULC, has received final approval from the FDA for its abbreviated new drug application for Zaleplon capsules, 5mg and 10mg.
Zaleplon capsules are the generic version of King Pharmaceuticals's Sonata capsules, which had US sales of approximately $88 million for the 12 months ended March 31, 2008, according to IMS Health.
This product is shipping immediately and will be sold under the Mylan Pharmaceuticals brand, the company said.
Source: Datamonitor
Related Articles
- Lu Returns to Earth in Soyuz Capsule
- Chinese Astronaut OK; Capsule Gets Checkup
- Chinese greet arrival of space capsule
- China Studies Returned Space Capsule
- Shenzhou Space Capsule Arrives in Beijing
- Shenzhou space capsule arrives in Chinese capital _ and is declared
- Wash. H.S. Time Capsule Disintegrates
- India plans to launch recoverable spacecraft capsule
- Japan Successfully Retrieves Space Capsule
- 'Fruit Capsule' May Lessen Artery Damage
Rate this article:
User Comments (0)
RSS Feeds